Product Information
ZAFIRLUKAST 20 MG TABLET is a generic product labeled by American Health Packaging, priced at $0.6436 per EA under NDC 68084005921. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Nov 18, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Zafirlukast market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
20 mg/1
Manufacturer
American Health PackagingNDC
68084005921
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ZAFIRLUKASTApproval Type
Generic (ANDA)
FDA Application
ANDA090372FDA Approved
11/18/2010
TE Code
AB
On Market Since
6/3/2013
Pharmacological Classes
Price Statistics
The NADAC for ZAFIRLUKAST 20 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 34.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6436 per EA |
|---|---|
| All-time high | $1.4485 (Jul 15, 2015) |
| All-time low | $0.4512 (Nov 20, 2024) |
| 52-week high | $0.6852 |
| 52-week low | $0.6359 |
| Median price | $1.1205 |
| Average price | $1.0682 |
| Largest weekly change | -33.6% (Nov 20, 2024) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZAFIRLUKAST 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZAFIRLUKAST 20 MG TABLET, manufactured by American Health Packaging, is $0.6436 per EA (NDC 68084005921), effective Aug 19, 2026.
How has the price of ZAFIRLUKAST 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZAFIRLUKAST 20 MG TABLET has declined 34.6%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZAFIRLUKAST 20 MG TABLET?
Since Nov 28, 2013, the NADAC for ZAFIRLUKAST 20 MG TABLET has ranged from a low of $0.4512 (Nov 20, 2024) to a high of $1.4485 (Jul 15, 2015), with a median of $1.1205 per EA.
Are there cheaper alternatives to ZAFIRLUKAST 20 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ZAFIRLUKAST 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ZAFIRLUKAST 20 MG TABLET?
ZAFIRLUKAST 20 MG TABLET (NDC 68084005921) is labeled by American Health Packaging, and CMS classifies it as a generic product.